Randox Liquid Cardiac Controls Recalled for N-proBNP Claim Removal
Randox Laboratories is recalling Liquid Cardiac Controls (CQ5051) to remove N-proBNP claims due to decreased recovery in recent lots.
What this means for you
Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.
Our severity reasoning: The recall is classified as FDA Class II, which typically corresponds to a moderate severity score when no specific injuries or illnesses are reported in the source text.
Plain-English summary
Randox Laboratories, Limited is recalling Randox Liquid Cardiac Controls, Catalogue Number CQ5051. The recall involves 6,208 units distributed in the United States and internationally.
The recall is initiated to remove claims for N-proBNP from the product. This action is taken due to an observed decrease in recovery for N-Terminal Pro-Brain Natriuretic Peptide (NT-proBNP) in recent lots. The affected lots include 4243CK, 4246CK, 4249CK, 4260CK, 4311CK, and 4317CK.
The product was distributed in the US states of WV, CA, DE, NJ, NY, GA, IN, and PR, as well as in numerous countries outside the US. Consumers and healthcare facilities should stop using the affected lots and contact the manufacturer for further instructions.
The recalled product
- Product
- Randox Liquid Cardiac Controls Catalogue Number CQ5051
- Manufacturer
- Randox Laboratories, Limited
- Hazard
- Affected units
- 6,208
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (5)
- 4246CK (Exp. 28Nov2019)
- 4249CK (Exp. 28Nov2019)
- 4260CK (Exp. 28Nov2019)
- 4311CK (Exp. 28May2020)
- 4317CK (Exp. 28May2020)
Distribution
Part of a larger recall action
This product is one of 3 recalled by Randox Laboratories, Limited under a single FDA (Devices) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 3 products in this recall →Related recalls
Same manufacturer · Randox Laboratories, Limited
See all →- HighRandox Lipoprotein (a) Diagnostic Assay Lacks FDA Clearance, Recalled
FDA (Devices) · 2025-01-29
- HighRandox Lipoprotein (a) assay distributed without required FDA clearance
FDA (Devices) · 2025-01-29
- ModerateRandox RX Daytona Plus Clinical Chemistry Analyzer Software Recall
FDA (Devices) · 2020-03-04
- ModerateRandox Liquid Cardiac Controls Recalled for N-proBNP Claim Removal
FDA (Devices) · 2019-11-27
- ModerateRandox Liquid Cardiac Controls Recalled for N-proBNP Claim Removal
FDA (Devices) · 2019-11-27
Same hazard · mis labeling
See all →- ModerateMedline Trach Tube Kit Recalled for Component Labeling Discrepancy
FDA (Devices) · 2026-09-02
- ModerateAVID Medical Recalls Halyard Total Joint Kits for Latex Labeling Deficiency
FDA (Devices) · 2026-09-02
- ModerateOlympus Recalls PowerSeal Sealer Due to Incorrect Outer Box Labeling
FDA (Devices) · 2026-09-02
- HighSura Tanmen Ramen Noodles Recalled for Undeclared Fish Allergens
FDA (Food) · 2026-09-02
- SevereWhite Vein Advanced Alkaloids Chewable Tablets Recall for Excess Active Ingredient
FDA (Food) · 2026-09-02